590 related articles for article (PubMed ID: 22538032)
1. Frequency of factor VIII (FVIII) inhibitor in haemophilia A.
Borhany M; Kumari M; Shamsi T; Naz A; Farzana T
J Coll Physicians Surg Pak; 2012 May; 22(5):289-93. PubMed ID: 22538032
[TBL] [Abstract][Full Text] [Related]
2. Successful low dose immune tolerance induction in severe haemophilia A with inhibitors below 40 Bethesda Units.
Ter Avest PC; Fischer K; Gouw SC; Van Dijk K; Mauser-Bunschoten EP
Haemophilia; 2010 May; 16(102):71-9. PubMed ID: 20536988
[TBL] [Abstract][Full Text] [Related]
3. FVIII and FIX inhibitors in people living with hemophilia in Cameroon, Africa: a preliminary study.
Balôgôg PN; Tagny CT; Ndoumba A; Mbanya D
Int J Lab Hematol; 2014 Oct; 36(5):566-70. PubMed ID: 25356499
[TBL] [Abstract][Full Text] [Related]
4. Occurrence of inhibitors in previously untreated or minimally treated patients with haemophilia A after exposure to a plasma-derived solvent-detergent factor VIII concentrate.
Gringeri A; Monzini M; Tagariello G; Scaraggi FA; Mannucci PM;
Haemophilia; 2006 Mar; 12(2):128-32. PubMed ID: 16476086
[TBL] [Abstract][Full Text] [Related]
5. Thrombin generation as objective parameter of treatment response in patients with severe haemophilia A and high-titre inhibitors.
Luna-Záizar H; Beltrán-Miranda CP; Esparza-Flores MA; Soto-Padilla J; Bergés-García A; Rodríguez-Zepeda MD; Pompa-Garza MT; Jaloma-Cruz AR
Haemophilia; 2014 Jan; 20(1):e7-14. PubMed ID: 24354488
[TBL] [Abstract][Full Text] [Related]
6. Immune tolerance induction with a high purity von Willebrand factor/VIII complex concentrate in haemophilia A patients with inhibitors at high risk of a poor response.
Gringeri A; Musso R; Mazzucconi MG; Piseddu G; Schiavoni M; Pignoloni P; Mannucci PM;
Haemophilia; 2007 Jul; 13(4):373-9. PubMed ID: 17610550
[TBL] [Abstract][Full Text] [Related]
7. Tyr2105Cys mutation in exon 22 of FVIII gene is a risk factor for the development of inhibitors in patients with mild/moderate haemophilia A.
Franchini M; Girelli D; Olivieri O; Castaman G; Lippi G; Poli G; Salvagno GL; Tagariello G; Giuffrida A; de Gironcoli M; Morfini M; Berntorp E; Gandini G
Haemophilia; 2006 Jul; 12(4):448-51. PubMed ID: 16834751
[TBL] [Abstract][Full Text] [Related]
8. The long-term course of factor VIII inhibitors in patients with congenital haemophilia A without immune tolerance induction.
Caram C; de Souza RG; de Sousa JC; Araújo Pereira T; do Amaral Cerqueira AM; van der Bom JG; Rezende SM
Thromb Haemost; 2011 Jan; 105(1):59-65. PubMed ID: 21057702
[TBL] [Abstract][Full Text] [Related]
9. Prompt immune tolerance induction at inhibitor diagnosis regardless of titre may increase overall success in haemophilia A complicated by inhibitors: experience of two U.S. centres.
Nakar C; Manco-Johnson MJ; Lail A; Donfield S; Maahs J; Chong Y; Blades T; Shapiro A
Haemophilia; 2015 May; 21(3):365-373. PubMed ID: 25581638
[TBL] [Abstract][Full Text] [Related]
10. Low risk of inhibitor formation in haemophilia A patients following en masse switch in treatment to a third generation full length plasma and albumin-free recombinant factor VIII product (ADVATE®).
Bacon CL; Singleton E; Brady B; White B; Nolan B; Gilmore RM; Ryan C; Keohane C; Jenkins PV; O'Donnell JS
Haemophilia; 2011 May; 17(3):407-11. PubMed ID: 21382134
[TBL] [Abstract][Full Text] [Related]
11. Immune tolerance induction in haemophilia A patients with inhibitors by treatment with recombinant factor VIII: a retrospective non-interventional study.
Rivard GE; Rothschild C; Toll T; Achilles K
Haemophilia; 2013 May; 19(3):449-55. PubMed ID: 23510123
[TBL] [Abstract][Full Text] [Related]
12. Influence of the type of F8 gene mutation on inhibitor development in a single centre cohort of severe haemophilia A patients.
Gouw SC; Van Der Bom JG; Van Den Berg HM; Zewald RA; Ploos Van Amstel JK; Mauser-Bunschoten EP
Haemophilia; 2011 Mar; 17(2):275-81. PubMed ID: 21070499
[TBL] [Abstract][Full Text] [Related]
13. [Factor VIII inhibitors in patients suffering from severe haemophilia A: problems of "very low" responders].
Lutze G; Aumann V; Lutze G; Mittler U
Klin Padiatr; 2001; 213(6):321-4. PubMed ID: 11713709
[TBL] [Abstract][Full Text] [Related]
14. Low risk of inhibitor formation in haemophilia patients after a change in treatment from Chinese hamster ovary cell-produced to baby hamster kidney cell-produced recombinant factor VIII.
Singleton E; Smith J; Kavanagh M; Nolan B; White B
Thromb Haemost; 2007 Dec; 98(6):1188-92. PubMed ID: 18064312
[TBL] [Abstract][Full Text] [Related]
15. Risk of inhibitor development in mild haemophilia A increases with age.
Mauser-Bunschoten EP; Den Uijl IE; Schutgens RE; Roosendaal G; Fischer K
Haemophilia; 2012 Mar; 18(2):263-7. PubMed ID: 21851507
[TBL] [Abstract][Full Text] [Related]
16. Rituximab for the treatment of patients with very high-titre acquired factor VIII inhibitors refractory to conventional chemotherapy.
Field JJ; Fenske TS; Blinder MA
Haemophilia; 2007 Jan; 13(1):46-50. PubMed ID: 17212724
[TBL] [Abstract][Full Text] [Related]
17. Treatment of haemophilia A in Tunisia: efficacy and inhibitor study.
Houissa B; Mliki ML; Abdelkafi S; Bouslama M; Zaïer M; Mahjoub T; Kortas M; Ghachem L; Yacoub S
Hamostaseologie; 2003 Aug; 23(3):144-8. PubMed ID: 12923586
[TBL] [Abstract][Full Text] [Related]
18. Development of inhibitors in haemophilia. Ongoing epidemiological study.
Serban M; Mihailov D; Pop L; Ionita H; Ursu E; Talpos-Niculescu S; Ritli L; Baghiu D; Uscatescu V; Petrovanu C; Stancu P; Savescu D; Cucuianu A; Schramm W
Hamostaseologie; 2011 Nov; 31 Suppl 1():S20-3. PubMed ID: 22057218
[TBL] [Abstract][Full Text] [Related]
19. Low-dose immune tolerance induction for paediatric haemophilia patients with factor VIII inhibitors.
Unuvar A; Kavakli K; Baytan B; Kazanci E; Sayli T; Oren H; Celkan T; Gursel T
Haemophilia; 2008 Mar; 14(2):315-22. PubMed ID: 18081830
[TBL] [Abstract][Full Text] [Related]
20. First prospective report on immune tolerance in poor risk haemophilia A inhibitor patients with a single factor VIII/von Willebrand factor concentrate in an observational immune tolerance induction study.
Kreuz W; Escuriola Ettingshausen C; Vdovin V; Zozulya N; Plyushch O; Svirin P; Andreeva T; Bubanská E; Campos M; Benedik-Dolničar M; Jiménez-Yuste V; Kitanovski L; Klukowska A; Momot A; Osmulskaya N; Prieto M; Šalek SZ; Velasco F; Pavlova A; Oldenburg J; Knaub S; Jansen M; Belyanskaya L; Walter O; ;
Haemophilia; 2016 Jan; 22(1):87-95. PubMed ID: 26202305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
